If a clinician chooses to employ GHK-Cu, record justification and begin at a low level
This method deposits the active tripeptide into cells where standard oral powders fail
Our team ensures maximum comfort, safety, and visible results tailored to your aesthetic goals
Given that some mutant enzymes retain low-level FAD-binding capacity, a gene + high-dose riboflavin synergy strategy has been proposed: in AIFM1 encephalopathies, low-level AAV transduction re-establishes baseline protein expression, while daily riboflavin doses above 400 mg act as a molecular chaperone to stabilize FAD binding a regimen shown to improve ICARS scores and neuroimaging outcomes (54, 75)
n = 4 mice for each genotype
This product is presented in a pharmaceutical-grade dosage form, free from excipients, additives, preservatives, artificial colors, or flavors